Concentra Group Holdings Parent, Inc. CON NYSE · Healthcare · United States
$42.56 -1.01% -$0.44
Summary
55 / 100 · Bulios Score
What speaks for it
- Out of every 100 USD of revenue, 11 USD is left as free cash.
- It passes 8 of the 9 points of the Piotroski financial health test.
What to watch
- The share price is above the Bulios Fair Price.
- Repaying its net debt would take 4.3 years of operating profit.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBy our assumptions the business is worth less than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 25.1 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 7.9% a year over the last 3 years. For the next fiscal year analysts expect revenue to grow by 8.7%. Earnings per share fell by 0.5% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 70 USD
- Sales and administration 13 USD
- Taxes and other 7.7 USD
- Net profit 9.3 USD
Net profit, industry median (Medical - Care Facilities) 7.3 USD
Out of every 100 USD of revenue, 9.3 USD is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 8.3 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 0.58%
- Paid out of profit
- 15%
You receive $0.25 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 8
- Hold 0
- Sell 0
Today's price within the analysts' price targets
The average target of $40 is 6.0% below today's price. 100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.